These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 2874464)

  • 61. [Cimetidine, ranitidine and somatostatin in the medical treatment of acute and chronic Zollinger-Ellison syndrome].
    Gordillo J; Varas MJ
    Rev Esp Enferm Apar Dig; 1987 Dec; 72(6):749-50. PubMed ID: 2894045
    [No Abstract]   [Full Text] [Related]  

  • 62. Histamine H2-receptor antagonists in the treatment of peptic ulcer disease.
    Wood JR; McIsaac RL
    S Afr Med J; 1988 Jul; 74 Suppl():51-4. PubMed ID: 3291155
    [No Abstract]   [Full Text] [Related]  

  • 63. [The H2-antagonist therapy withdrawal syndrome: the possible role of hyperprolactinemia].
    Rampello L; Nicoletti G
    Medicina (Firenze); 1990; 10(3):294-6. PubMed ID: 1981922
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Interest of ranitidine, a new H2 receptor antagonist in the treatment of Zollinger-Ellison syndrome (author's transl)].
    Mignon M; Vallot T; Mayeur S; Treffot MJ; Bonfils S
    Gastroenterol Clin Biol; 1981 Jan; 5(1):42-7. PubMed ID: 6110608
    [No Abstract]   [Full Text] [Related]  

  • 65. Histamine H2-receptor antagonists have no clinically significant effect on the steady-state pharmacokinetics of voriconazole.
    Purkins L; Wood N; Kleinermans D; Nichols D
    Br J Clin Pharmacol; 2003 Dec; 56 Suppl 1(Suppl 1):51-5. PubMed ID: 14616414
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Cimetidine vs ranitidine.
    Montgomery H
    J Kans Med Soc; 1983 Dec; 84(12):605. PubMed ID: 6317776
    [No Abstract]   [Full Text] [Related]  

  • 67. Cholinergic effects of histamine-H2 receptor antagonists partly through inhibition of acetylcholinesterase.
    Aono M; Moriga M; Mizuta K; Narusawa H
    Gastroenterol Jpn; 1986 Jun; 21(3):213-9. PubMed ID: 2874096
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Effects of cimetidine and ranitidine on hepatic drug metabolism.
    Breen KJ; Bury R; Desmond PV; Mashford ML; Morphett B; Westwood B; Shaw RG
    Clin Pharmacol Ther; 1982 Mar; 31(3):297-300. PubMed ID: 6120774
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Lack of interaction between zolpidem and H2 antagonists, cimetidine and ranitidine.
    Hulhoven R; Desager JP; Harvengt C; Hermann P; Guillet P; Thiercelin JF
    Int J Clin Pharmacol Res; 1988; 8(6):471-6. PubMed ID: 3253224
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Protection by cimetidine, but not ranitidine, implies that H2 receptors do not mediate arrhythmogenesis in a rat model of regional ischaemia and reperfusion in vitro.
    Banning MM; Curtis MJ
    Cardiovasc Res; 1995 Nov; 30(5):705-10. PubMed ID: 8595616
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Clinical aspects of cardiovascular effects of H2-receptor antagonists.
    Hinrichsen H; Halabi A; Kirch W
    J Clin Pharmacol; 1995 Feb; 35(2):107-16. PubMed ID: 7751419
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Ranitidine. An updated review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in peptic ulcer disease and other allied diseases.
    Grant SM; Langtry HD; Brogden RN
    Drugs; 1989 Jun; 37(6):801-70. PubMed ID: 2667937
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Clinical review of histamine2 receptor antagonists.
    Lipsy RJ; Fennerty B; Fagan TC
    Arch Intern Med; 1990 Apr; 150(4):745-51. PubMed ID: 1970232
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Effect of cimetidine and ranitidine on carbamazepine and sodium valproate pharmacokinetics.
    Webster LK; Mihaly GW; Jones DB; Smallwood RA; Phillips JA; Vajda FJ
    Eur J Clin Pharmacol; 1984; 27(3):341-3. PubMed ID: 6096154
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Isolation of human hepatic microsomes and their inhibition by cimetidine and ranitidine.
    Hoensch HP; Hutzel H; Kirch W; Ohnhaus EE
    Eur J Clin Pharmacol; 1985; 29(2):199-206. PubMed ID: 3935464
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Therapeutic approach in patients with concomitant disease/drug--drug interactions (roxatidine acetate).
    Collins JD
    Scand J Gastroenterol Suppl; 1988; 146():89-99. PubMed ID: 2906472
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [H2-receptor antagonists. 10 questions--10 answers].
    Koelz HR
    Schweiz Rundsch Med Prax; 1984 Jun; 73(26):831-4. PubMed ID: 6089295
    [No Abstract]   [Full Text] [Related]  

  • 78. The treatment of "cimetidine resistant" peptic ulcers by ranitidine hydrochloride: a new histamine H2-receptor antagonist.
    Mohammed R; Mitchell KG; Mackay C
    Curr Med Res Opin; 1981; 7(8):523-5. PubMed ID: 6118237
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Single blind comparative study of ranitidine and cimetidine in patients with gastric ulcer. The Belgian Peptic Ulcer Study Group.
    Gut; 1984 Sep; 25(9):999-1002. PubMed ID: 6088368
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Cimetidine and ranitidine may not cross-react to cause thrombocytopenia.
    Shalev O; Seror D
    J Intern Med; 1991 Jul; 230(1):87-8. PubMed ID: 2066715
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.